The DOI matches its Crossref record; 232 of the 232 references it cites were found in a registry or an index.
Parenteral anticoagulants in heart disease: Current status and perspectives (Section II): Position Paper of the ESC Working Group on Thrombosis – Task Force on Anticoagulants in Heart Disease
Abstract
Summary: Anticoagulants are a mainstay of cardiovascular therapy, and parenteral anticoagulants have widespread use in cardiology, especially in acute situations. Parenteral anticoagulants include unfractionated heparin, low-molecular-weight heparins, the synthetic pentasaccharides fondaparinux, idraparinux and idrabiotaparinux, and parenteral direct thrombin inhibitors. The several shortcomings of unfractionated heparin and of low-molecular-weight heparins have prompted the development of the other newer agents. Here we review the mechanisms of action, pharmacological properties and side effects of parenteral anticoagulants used in the management of coronary heart disease treated with or without percutaneous coronary interventions, cardioversion for atrial fibrillation, and prosthetic heart valves and valve repair. Using an evidence-based approach, we describe the results of completed clinical trials, highlight ongoing research with currently available agents, and recommend therapeutic options for specific heart diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–232 of 232
Ansell, J. (2012) · Circulation · doi:10.1161/circulationaha.111.031153 · Cited by 71
The Search for Replacements for Unfractionated Heparin
Antman, E. M. (2001) · Circulation · doi:10.1161/01.cir.103.18.2310 · Cited by 68
Borobia, A. M., Lubomirov, R., Ramı́rez, E., Lorenzo, A., Campos, A., Romo, R. M., Fernández‐Capitán, C., Frías, J., & Carcas, A. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041360 · Cited by 65
Lip, G. Y. H., Lin, H., Chien, K., Hsu, H., Su, T., Chen, M.-F., & Lee, Y. (2012) · International Journal of Cardiology · doi:10.1016/j.ijcard.2012.09.148 · Cited by 65
Self-citationSystematic review of studies of self-management of oral anticoagulation
Berghold, A., Sawicki, P. T., & Siebenhofer, A. (2004) · Thrombosis and Haemostasis · doi:10.1160/th03-09-0598 · Cited by 63
Liang, R., Li, L., Li, C., Gao, Y., Liu, W., Hu, D., & Sun, Y. (2012) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-012-0725-7 · Cited by 62
Buller, H. R., Gallus, A. S., Pillion, G., Prins, M. H., & Raskob, G. E. (2011) · The Lancet · doi:10.1016/s0140-6736(11)61505-5 · Cited by 60
Casele, H. L., & Laifer, S. A. (2000) · The Journal of Maternal-Fetal Medicine · doi:10.1002/(sici)1520-6661(200003/04)9:2<122::aid-mfm7>3.0.co;2-q · Cited by 60
Herlitz, J. D. (2004) · European Heart Journal · doi:10.1016/j.ehj.2003.10.026 · Cited by 60
ten Berg, J. M., Kelder, J. C., SUTTORP, M. J., et al. (2000) · Circulation · doi:10.1161/01.cir.102.4.386 · Cited by 58
Inhibition by heparin of the human blood coagulation intrinsic pathway factor X activator.
Barrow, R. T., Parker, E. T., Krishnaswamy, S., et al. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47089-5 · Cited by 54
Effect of Rosuvastatin on Warfarin Pharmacodynamics and Pharmacokinetics
Simonson, S. G., Martin, P. D., Mitchell, P., Lasseter, K. C., Gibson, G. L., & Schneck, D. W. (2005) · The Journal of Clinical Pharmacology · doi:10.1177/0091270005278224 · Cited by 52
Rasmussen, L. H., Larsen, T. B., Due, K. M., Tjønneland, A. M., Overvad, K., & Lip, G. Y. H. (2011) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2011.04308.x · Cited by 48
Self-citationNancy-Portebois, V., Dubreucq, G., Motte, V., de Kort, M., van Boeckel, C. A. A., Vogel, G. M. T., Wisse, J. A. J., Petitou, M., & Meuleman, D. G. (2009) · Thrombosis and Haemostasis · doi:10.1160/th09-01-0063 · Cited by 46
Lip, G. Y. H., Lin, H., Hsu, H., Su, T., Chen, M.-F., Lee, Y., & Chien, K. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2012.12.076 · Cited by 46
Self-citationAndersson, M. L., Eliasson, E., & Lindh, J. D. (2012) · Pharmacogenomics · doi:10.2217/pgs.12.40 · Cited by 43
Blood Coagulation in Patients with Chronic Heart Failure
Lorenzo, F. D., Saba, N., & Kakkar, V. V. (2003) · Drugs · doi:10.2165/00003495-200363060-00004 · Cited by 40
Clarke, K., Taberner, D. A., THOMSON, J. M., Morris, J. A., & Poller, L. (1992) · Journal of Clinical Pathology · doi:10.1136/jcp.45.1.58 · Cited by 38
Subcutaneous enoxaparin with early invasive strategy in patients with acute coronary syndromes
Collet, J. ‐., Montalescot, G., Golmard, J., Tanguy, M., Ankri, A., Choussat, R., Beygui, F., Drobinski, G., Vignolles, N., & Thomas, D. (2004) · American Heart Journal · doi:10.1016/j.ahj.2003.10.019 · Cited by 34
Tay, K. H., Lane, D. A., & Lip, G. Y. H. (2008) · Thrombosis and Haemostasis · doi:10.1160/th08-10-0685 · Cited by 31
Self-citationGains and losses of warfarin therapy as performed in an anticoagulation clinic
Njaastad, A. M., Abildgaard, U., & Lassen, J. F. (2006) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2005.01605.x · Cited by 30
Poller, L., Ibrahim, S., Keown, M., Pattison, A., & Jespersen, J. (2010) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2010.04109.x · Cited by 25
Self-citationPlenty of pills: polypharmacy prevails in patients of a Danish anticoagulant clinic
Skov, J., Bladbjerg, E., Sidelmann, J. J., Vámosi, M., & Jespersen, J. (2011) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-011-1045-0 · Cited by 23
Self-citationPoller, L., Ibrahim, S., Keown, M., Pattison, A., & Jespersen, J. (2010) · Clinical Chemistry · doi:10.1373/clinchem.2009.141937 · Cited by 21
Self-citationGenotype-Based Dosing Algorithms for Warfarin Therapy
Johnson, E., Horne, B. D., Carlquist, J. F., & Anderson, J. L. (2011) · Molecular Diagnosis & Therapy · doi:10.1007/bf03256417 · Cited by 18
van Schie, R. M., BABAJEFF, A. M. V., Schalekamp, T., et al. (2012) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2012.04694.x · Cited by 17
Pharmacokinetic and Pharmacodynamic Variability of Fluindione in Octogenarians
Comets, E., Diquet, B., Legrain, S., Huisse, M., Godon, A., Bruhat, C., Chauveheid, M., Delpierre, S., Duval, X., Berrut, G., et al. (2012) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2011.309 · Cited by 10
New Therapies for Stroke Prevention in Atrial Fibrillation: The Long Road to Enhanced Efficacy
Freedman, J. E., & Gersh, B. J. (2009) · Circulation · doi:10.1161/circulationaha.109.893362 · Cited by 9
Poller, L., Jespersen, J., Ibrahim, S. A., & Pattison, A. (2013) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12164 · Cited by 8
Self-citationAntithrombotic Strategies in non-ST Elevation Acute Coronary Syndromes: Focus On Bivalirudin
Nikolsky, E., & Stone, G. W. (2007) · Future Cardiology · doi:10.2217/14796678.3.4.345 · Cited by 8
Enoxaparin versus Unfractionated Heparin in ST-Elevation Myocardial Infarction
Sleight, P., Eikelboom, J. W., & Bassand, J. (2006) · New England Journal of Medicine · doi:10.1056/nejmc061197 · Cited by 7
Antithrombotic Management in Patients with Prosthetic Valves
Butchart, E. G., & Caterina, R. D. (2012) · Wiley eBooks · doi:10.1002/9781118410875.ch17 · Cited by 5
Cited by
Hindricks, G., Potpara, T., Dagres, N., Arbelo, E., Bax, J. J., Blomström-Lundqvist, C., Boriani, G., Castella, M., Dan, G.-A., Dilaveris, P. E., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehaa612 · Cited by 9,971
Self-citation2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Kirchhof, P., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., Castella, M., Diener, H.-C., Heidbuchel, H., Hendriks, J., et al. (2016) · Europace · doi:10.1093/europace/euw295 · Cited by 6,439
Self-citation2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Kirchhof, P., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., Castella, M., Diener, H.-C., Heidbuchel, H., Hendriks, J., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw210 · Cited by 6,418
Self-citation2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism
Authors/Task Force Members, Konstantinides, S. V., Torbicki, A., Agnelli, G., Danchin, N., Fitzmaurice, D., Galiè, N., Gibbs, J. S. R., Huisman, M. V., Humbert, M., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu283 · Cited by 3,128
Self-citation2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Kirchhof, P., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., Castella, M., Diener, H.-C., Heidbuchel, H., Hendriks, J., et al. (2016) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezw313 · Cited by 1,403
Self-citation
Metadata
- Authors
- Husted, S., Wallentin, L., Andreotti, F., Arnesen, H., Bachmann, F., Baigent, C., Huber, K., Jespersen, J., Kristensen, S., Lip, G. Y. H., Morais, J., Rasmussen, L., Siegbahn, A., Verheugt, F. W. A., Weitz, J. I., & De Caterina, R.
- Venue
- Thrombosis and Haemostasis
- Publisher
- Georg Thieme Verlag KG
- Published
- 2013
- Volume
- 109
- Issue
- 05
- Pages
- 769-786
- ISSN
- 0340-6245 (ISSN-L)
- 2567-689X
- OpenAlex
- W1970914415
- Cited by
- 364
- References
- 232
- FWCI
- 46.71
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.